Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide once-weekly effects on gastric emptying and glucose absorption in healthy older adults
ACTRN12616000955415Phase 2Completed
- Sponsor
- Royal Adelaide Hospital
- Start
- Oct 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Exenatide once weekly with Placebo (2 arms). Primary endpoint: Gastric emptying. Started Oct 2016; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ACTRN12616000955415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000955415.